Zydus receives final approval from USFDA for Aspirin and Dipyridamole capsules

Zydus Cadila has received the final approval from the USFDA to market Aspirin & extended-release Dipyridamole capsules in the strengths of 25 mg/200 mg.

August 30, 2017 / 11:01 IST

live

bselive
nselive

Volume

Todays L/H

Zydus receives final approval from the USFDA for Aspirin and Extended-Release Dipyridamole CapsulesSource : BSE

first published: Aug 30, 2017 11:01 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347